Hemangiol, Post Marketing Surveillance Study
NCT04105517
·
clinicaltrials.gov ↗
COMPLETED
Status
500
Enrollment
OTHER
Sponsor class
Conditions
Infantile Hemangioma
Sponsor
University Hospital, Montpellier